Camurus to present at Jefferies 2019 London Healthcare Conference
Lund, Sweden — 21 October 2019 — Camurus (Nasdaq Stockholm; CAMX) today announced that that the Company will present at the Jefferies 2019 London Healthcare Conference 20 November at 2:00 pm local time (GMT). Fredrik Tiberg, President and CEO, will report on the progress of Buvidal® launches and sales in the EU and Australia and recent development in Camurus’ pipeline of innovative medicines. A webcast of the presentation can be accessed via http://wsw.com/webcast/jeff123/camx.st/. About CamurusCamurus is a Swedish science-led biopharmaceutical company committed to developing and